Plant polyphenols in cancer and heart disease

implications as nutritional antioxidants

Garry G. Duthie, Susan J. Duthie, Janet Kyle

Research output: Contribution to journalArticle

508 Citations (Scopus)

Abstract

Certain dietary antioxidants such as vitamin E and vitamin C are important for maintaining optimum health. There is now much interest in polyphenolic products of the plant phenylpropanoid pathway as they have considerable antioxidant activity in vitro and are ubiquitous in our diet. Rich sources include tea, wine, fruits and vegetables although levels are affected by species, light, degree of ripeness, processing and storage. This confounds the formulation of databases for the estimation of dietary intakes. Most attention to date has focused on the flavonoids, a generic term which includes chalcones, flavones, flavanones, flavanols and anthocyanins. There is little convincing epidemiological evidence that intakes of polyphenols are inversely related to the incidence of cancer whereas a number of studies suggest that high intakes of flavonoids may be protective against CHD. In contrast, numerous cell culture and animal models indicate potent anticarcinogenic activity by certain polyphenols mediated through a range of mechanisms including antioxidant activity, enzyme modulation, gene expression, apoptosis, upregulation of gap junction communication and P-glycoprotein activation. Possible protective effects against heart disease may be due to the ability of some polyphenols to prevent the oxidation of LDL to an atherogenic form although anti-platelet aggregation activity and vasodilatory properties are also reported. However, some polyphenols are toxic in mammalian cells. Thus, until more is known about their bioavailability, metabolism and intracellular location, increasing intakes of polyphenols by supplements or food fortification may be unwise.

Original languageEnglish
Pages (from-to)79-106
Number of pages28
JournalNutrition Research Reviews
Volume13
Issue number1
DOIs
Publication statusPublished - Jun 2000

Keywords

  • polyphenols
  • cancer
  • heart disease
  • antioxidants
  • bioavailability
  • low-density-lipoprotein
  • potentially anticarcinogenic flavonoids
  • nuclear-dna damage
  • junctional intercellular communication
  • dietary quercetin glycosides
  • drug-metabolizing-enzymes
  • liver epithelial-cells
  • green tea polyphenols
  • oxygen-free-radicals
  • lipid-peroxidation

Cite this

Plant polyphenols in cancer and heart disease : implications as nutritional antioxidants. / Duthie, Garry G.; Duthie, Susan J.; Kyle, Janet.

In: Nutrition Research Reviews, Vol. 13, No. 1, 06.2000, p. 79-106.

Research output: Contribution to journalArticle

@article{a346176c64dc4a70939413b5ec83adea,
title = "Plant polyphenols in cancer and heart disease: implications as nutritional antioxidants",
abstract = "Certain dietary antioxidants such as vitamin E and vitamin C are important for maintaining optimum health. There is now much interest in polyphenolic products of the plant phenylpropanoid pathway as they have considerable antioxidant activity in vitro and are ubiquitous in our diet. Rich sources include tea, wine, fruits and vegetables although levels are affected by species, light, degree of ripeness, processing and storage. This confounds the formulation of databases for the estimation of dietary intakes. Most attention to date has focused on the flavonoids, a generic term which includes chalcones, flavones, flavanones, flavanols and anthocyanins. There is little convincing epidemiological evidence that intakes of polyphenols are inversely related to the incidence of cancer whereas a number of studies suggest that high intakes of flavonoids may be protective against CHD. In contrast, numerous cell culture and animal models indicate potent anticarcinogenic activity by certain polyphenols mediated through a range of mechanisms including antioxidant activity, enzyme modulation, gene expression, apoptosis, upregulation of gap junction communication and P-glycoprotein activation. Possible protective effects against heart disease may be due to the ability of some polyphenols to prevent the oxidation of LDL to an atherogenic form although anti-platelet aggregation activity and vasodilatory properties are also reported. However, some polyphenols are toxic in mammalian cells. Thus, until more is known about their bioavailability, metabolism and intracellular location, increasing intakes of polyphenols by supplements or food fortification may be unwise.",
keywords = "polyphenols, cancer, heart disease, antioxidants, bioavailability, low-density-lipoprotein, potentially anticarcinogenic flavonoids, nuclear-dna damage, junctional intercellular communication, dietary quercetin glycosides, drug-metabolizing-enzymes, liver epithelial-cells, green tea polyphenols, oxygen-free-radicals, lipid-peroxidation",
author = "Duthie, {Garry G.} and Duthie, {Susan J.} and Janet Kyle",
year = "2000",
month = "6",
doi = "10.1079/095442200108729016",
language = "English",
volume = "13",
pages = "79--106",
journal = "Nutrition Research Reviews",
issn = "0954-4224",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Plant polyphenols in cancer and heart disease

T2 - implications as nutritional antioxidants

AU - Duthie, Garry G.

AU - Duthie, Susan J.

AU - Kyle, Janet

PY - 2000/6

Y1 - 2000/6

N2 - Certain dietary antioxidants such as vitamin E and vitamin C are important for maintaining optimum health. There is now much interest in polyphenolic products of the plant phenylpropanoid pathway as they have considerable antioxidant activity in vitro and are ubiquitous in our diet. Rich sources include tea, wine, fruits and vegetables although levels are affected by species, light, degree of ripeness, processing and storage. This confounds the formulation of databases for the estimation of dietary intakes. Most attention to date has focused on the flavonoids, a generic term which includes chalcones, flavones, flavanones, flavanols and anthocyanins. There is little convincing epidemiological evidence that intakes of polyphenols are inversely related to the incidence of cancer whereas a number of studies suggest that high intakes of flavonoids may be protective against CHD. In contrast, numerous cell culture and animal models indicate potent anticarcinogenic activity by certain polyphenols mediated through a range of mechanisms including antioxidant activity, enzyme modulation, gene expression, apoptosis, upregulation of gap junction communication and P-glycoprotein activation. Possible protective effects against heart disease may be due to the ability of some polyphenols to prevent the oxidation of LDL to an atherogenic form although anti-platelet aggregation activity and vasodilatory properties are also reported. However, some polyphenols are toxic in mammalian cells. Thus, until more is known about their bioavailability, metabolism and intracellular location, increasing intakes of polyphenols by supplements or food fortification may be unwise.

AB - Certain dietary antioxidants such as vitamin E and vitamin C are important for maintaining optimum health. There is now much interest in polyphenolic products of the plant phenylpropanoid pathway as they have considerable antioxidant activity in vitro and are ubiquitous in our diet. Rich sources include tea, wine, fruits and vegetables although levels are affected by species, light, degree of ripeness, processing and storage. This confounds the formulation of databases for the estimation of dietary intakes. Most attention to date has focused on the flavonoids, a generic term which includes chalcones, flavones, flavanones, flavanols and anthocyanins. There is little convincing epidemiological evidence that intakes of polyphenols are inversely related to the incidence of cancer whereas a number of studies suggest that high intakes of flavonoids may be protective against CHD. In contrast, numerous cell culture and animal models indicate potent anticarcinogenic activity by certain polyphenols mediated through a range of mechanisms including antioxidant activity, enzyme modulation, gene expression, apoptosis, upregulation of gap junction communication and P-glycoprotein activation. Possible protective effects against heart disease may be due to the ability of some polyphenols to prevent the oxidation of LDL to an atherogenic form although anti-platelet aggregation activity and vasodilatory properties are also reported. However, some polyphenols are toxic in mammalian cells. Thus, until more is known about their bioavailability, metabolism and intracellular location, increasing intakes of polyphenols by supplements or food fortification may be unwise.

KW - polyphenols

KW - cancer

KW - heart disease

KW - antioxidants

KW - bioavailability

KW - low-density-lipoprotein

KW - potentially anticarcinogenic flavonoids

KW - nuclear-dna damage

KW - junctional intercellular communication

KW - dietary quercetin glycosides

KW - drug-metabolizing-enzymes

KW - liver epithelial-cells

KW - green tea polyphenols

KW - oxygen-free-radicals

KW - lipid-peroxidation

U2 - 10.1079/095442200108729016

DO - 10.1079/095442200108729016

M3 - Article

VL - 13

SP - 79

EP - 106

JO - Nutrition Research Reviews

JF - Nutrition Research Reviews

SN - 0954-4224

IS - 1

ER -